Inovio Pharmaceuticals (INO)

P/S ratio as of September 2024 (TTM): 293

According to Inovio Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 293.484. At the end of 2024 the company had a P/S ratio of 354.

P/S ratio history for Inovio Pharmaceuticals from 2001 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	354	111.39%
2023	167	341.21%
2022	37.9	-93.59%
2021	592	192.41%
2020	202	148.69%
2019	81.3	537.59%
2018	12.8	44.44%
2017	8.83	-39.22%
2016	14.5	21.49%
2015	12.0	-77.57%
2014	53.3	17.75%
2013	45.3	158.75%
2012	17.5	214.73%
2011	5.56	-71.71%
2010	19.7	53.06%
2009	12.8	17.71%
2008	10.9	30.14%
2007	8.38	-75.2%
2006	33.8	176.32%
2005	12.2	-80.32%
2004	62.2	-93.71%
2003	988	1227.56%
2002	74.5	2126.05%
2001	3.34

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Pfizer PFE	3.02	-98.97%	🇺🇸 USA
Johnson & Johnson JNJ	4.58	-98.44%	🇺🇸 USA
Arrowhead Pharmaceuticals ARWR	134	-54.43%	🇺🇸 USA
Novartis NVS	4.81	-98.36%	🇨🇭 Switzerland
Merck MRK	4.76	-98.38%	🇺🇸 USA
GlaxoSmithKline GSK	2.16	-99.27%	🇬🇧 UK
Gilead Sciences GILD	3.76	-98.72%	🇺🇸 USA
Cleveland BioLabs CBLI	N/A	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Inovio Pharmaceuticals (INO)

P/S ratio as of September 2024 (TTM): 293